In the article is this paragraph: Dr Paul Brennan, a co-author of the Lancet paper and a hepatologist at NHS Tayside, said: “GLP-1s (including Wegovy and Mounja

In the article is this paragraph: Dr Paul Brennan, a co-author of the Lancet paper and a hepatologist at NHS Tayside, said: “GLP-1s (including Wegovy and Mounjaro) offer the potential to resynchronise our metabolism, by introducing feelings of satiety – fullness – and delaying the time the stomach takes to empty. These effects often result in reduced calorie intake, and improvements in how the liver handles nutrients as a result of weight loss, thus reducing scar tissue formation in the liver.”